title: EXUDATIVE RETINAL DETACHMENT CAUSED BY A CHOROIDAL NEOVASCULAR MEMBRANE IN HALLERMANN-STREIFF SYNDROME.
abstract: OBJECTIVE
  To report a case of exudative retinal detachment caused by a choroidal neovascular membrane in Hallermann-Streiff syndrome.
  
  
  METHODS
  The authors report a 7-year-old white male with Hallermann-Streiff syndrome who developed exudative retinal detachments secondary to choroidal neovascular membrane that resolved after off-label use of intravitreal injections of bevacizumab 1.25 mg.
  
  
  CONCLUSIONS
  Patients with Hallermann-Streiff syndrome and exudative retinal detachment present with choroidal neovascular membrane can respond well with intravitreal injections of anti-vascular endothelial growth factor.
authors.affiliation: Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Alaa
authors.initials: A
authors.lastname: AlAli
authors.affiliation: Department of Ophthalmology, Faculty of Medicine, Laval University, Quebec City, Canada.|Centre universitaire d'ophtalmologie, St-Sacrement Hospital, Quebec City, Canada.
authors.forename: Serge
authors.initials: S
authors.lastname: Bourgault
authors.affiliation: Department of Ophthalmology, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Ian
authors.initials: I
authors.lastname: Clark
authors.affiliation: Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Wai-Ching
authors.initials: WC
authors.lastname: Lam
mesh_terms: D020533:Angiogenesis Inhibitors / Q000008:administration & dosage; D000068258:Bevacizumab / Q000008:administration & dosage; D002648:Child; D020256:Choroidal Neovascularization / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D005122:Exudates and Transudates; D005451:Fluorescein Angiography / Q000379:methods; D005654:Fundus Oculi; D006210:Hallermann's Syndrome / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D058449:Intravitreal Injections; D008297:Male; D012163:Retinal Detachment / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*
chemical_list: D020533:Angiogenesis Inhibitors; D000068258:Bevacizumab